Showing 1 - 20 results of 28 for search 'De-pei Wu', query time: 0.06s Refine Results
  1. 1
    MYC-regulated lncRNA NEAT1 promotes B cell proliferation and lymphomagenesis via the miR-34b-5p-GLI1 pathway in diffuse large B-cell lymphoma

    MYC-regulated lncRNA NEAT1 promotes B cell proliferation and lymphomagenesis via the miR-34b-5p-GLI1 pathway in diffuse large B-cell lymphoma by Chong-Sheng Qian, Ling-Jie Li, Hai-Wen Huang, Hai-Fei Yang, De-Pei Wu

    Published 2020-03-01
    Get full text
    Article
  2. 2
    Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole

    Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole by Jia Chen, Feng Chen, Ying Wang, Ling-Yi Yang, Miao Miao, Yue Han, De-Pei Wu

    Published 2014-10-01
    Get full text
    Article
  3. 3
    Outcomes of venetoclax combined with homoharringtonine and cytarabine in fit adults patients with de novo adverse‐risk acute myeloid leukaemia: A single‐centre retrospective analysis

    Outcomes of venetoclax combined with homoharringtonine and cytarabine in fit adults patients with de novo adverse‐risk acute myeloid leukaemia: A single‐centre retrospective analys... by Bao‐Quan Song, Xin Kong, Yan Pu, Yin Liu, Jian Zhang, De‐Pei Wu, Hui‐Ying Qiu

    Published 2023-11-01
    Get full text
    Article
  4. 4
    Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion

    Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion by Hai-Ping Dai, Hai-Ping Dai, Hai-Ping Dai, Jia Yin, Jia Yin, Jia Yin, Zheng Li, Zheng Li, Zheng Li, Chun-Xiao Yang, Tin Cao, Ping Chen, Yun-Hui Zong, Ming-Qing Zhu, Ming-Qing Zhu, Ming-Qing Zhu, Xia-Ming Zhu, Xia-Ming Zhu, Xia-Ming Zhu, Sheng Xiao, De-Pei Wu, De-Pei Wu, De-Pei Wu, Xiao-Wen Tang, Xiao-Wen Tang, Xiao-Wen Tang

    Published 2020-03-01
    Get full text
    Article
  5. 5
    Pyrosequencing quantified methylation level of miR-124 predicts shorter survival for patients with myelodysplastic syndrome

    Pyrosequencing quantified methylation level of miR-124 predicts shorter survival for patients with myelodysplastic syndrome by Hong Wang, Tong-Tong Zhang, Song Jin, Hong Liu, Xiang Zhang, Chang-Geng Ruan, De-Pei Wu, Yue Han, Xiao-Qin Wang

    Published 2017-08-01
    Get full text
    Article
  6. 6
    Efficiency of anti‐VEGF therapy in central nervous system AML relapse: A case report and literature review

    Efficiency of anti‐VEGF therapy in central nervous system AML relapse: A case report and literature review by Han‐Yu Cao, Tao Tao, Xiang‐Dong Shen, Lian Bai, Chao‐Ling Wan, De‐Pei Wu, Jin‐Li Li, Sheng‐Li Xue

    Published 2022-02-01
    Get full text
    Article
  7. 7
    MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death

    MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death by Chao Ding, Su-Ning Chen, Roderick A. F. Macleod, Hans G. Drexler, Stefan Nagel, De-Pei Wu, Ai-Ning Sun, Hai-Ping Dai

    Published 2018-01-01
    Get full text
    Article
  8. 8
    P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL

    P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL by Chang-Ju Qu, Hai-Ling Liu, Rui Zou, Na-Na Ping, Qian Zhu, Xiao Zhang, Jia-Jie He, De-Pei Wu, Zheng-Ming Jin

    Published 2023-08-01
    Get full text
    Article
  9. 9
    Combination of venetoclax with BCR-ABL tyrosine kinase inhibitor as a therapeutic strategy for Philadelphia chromosome-positive leukemias

    Combination of venetoclax with BCR-ABL tyrosine kinase inhibitor as a therapeutic strategy for Philadelphia chromosome-positive leukemias by Jing-Ying Zou, Si-Man Huang, Hai-Xia Zhoub, Ming-Zhu Xu, Ai-Ning Sun, De-Pei Wu, Sheng-Li Xue, Tong-Tong Zhang

    Published 2023-12-01
    Get full text
    Article
  10. 10
    P1089: ZANUBRUTINIB-RITUXIMAB CHEMO-FREE THERAPY WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA

    P1089: ZANUBRUTINIB-RITUXIMAB CHEMO-FREE THERAPY WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA by Chang-Ju Qu, Rui Zou, Jia-Jie He, Na-Na Ping, Qian Zhu, Xiao Zhang, Fan Xia, Danqing Kong, De-Pei Wu, Zheng-Ming Jin

    Published 2023-08-01
    Get full text
    Article
  11. 11
    Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia

    Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia by Tiantian Chu, Hong Wang, Xin Lv, Jiaqian Qi, Yaqiong Tang, Yi Fan, Huiying Qiu, Xiaowen Tang, Chengcheng Fu, Changgeng Ruan, Yue Han, De-Pei Wu

    Published 2021-07-01
    Get full text
    Article
  12. 12
    Investigation of the risk factors to predict cytokine release syndrome in relapsed or refractory B-cell acute lymphoblastic leukemia patients receiving IL-6 knocking down anti-CD19 chimeric antigen receptor T-cell therapy

    Investigation of the risk factors to predict cytokine release syndrome in relapsed or refractory B-cell acute lymphoblastic leukemia patients receiving IL-6 knocking down anti-CD19... by Wen-Jie Gong, Wen-Jie Gong, Yan Qiu, Yan Qiu, Ming-Hao Li, Ming-Hao Li, Li-Yun Chen, Li-Yun Chen, Yan-Yan Li, Yan-Yan Li, Jing-Qiu Yu, Jing-Qiu Yu, Li-Qing Kang, Ai-Ning Sun, Ai-Ning Sun, De-Pei Wu, De-Pei Wu, Lei Yu, Lei Yu, Sheng-Li Xue, Sheng-Li Xue

    Published 2022-08-01
    Get full text
    Article
  13. 13
    Successful treatment of acute B lymphoblastic leukemia relapse in the skin and testicle by anti-CD19 CAR-T with IL-6 knocking down: a case report

    Successful treatment of acute B lymphoblastic leukemia relapse in the skin and testicle by anti-CD19 CAR-T with IL-6 knocking down: a case report by Ze-Fa Liu, Li-Yun Chen, Jin Wang, Li-qing Kang, Hua Tang, Yao Zhou, Hai-Xia Zhou, Ai-Ning Sun, De-Pei Wu, Sheng-Li Xue

    Published 2020-05-01
    Get full text
    Article
  14. 14
    Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

    Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients by Yu Wang, De-Pei Wu, Qi-Fa Liu, Lan-Ping Xu, Kai-Yan Liu, Xiao-Hui Zhang, Wen-Jing Yu, Yang Xu, Fen Huang, Xiao-Jun Huang

    Published 2019-09-01
    Get full text
    Article
  15. 15
    Successful application of anti-CD19 CAR-T therapy with IL-6 knocking down to patients with central nervous system B-cell acute lymphocytic leukemia

    Successful application of anti-CD19 CAR-T therapy with IL-6 knocking down to patients with central nervous system B-cell acute lymphocytic leukemia by Li-Yun Chen, Li-Qing Kang, Hai-Xia Zhou, Han-Qing Gao, Xue-Fei Zhu, Nan Xu, Lei Yu, De-Pei Wu, Sheng-Li Xue, Ai-Ning Sun

    Published 2020-11-01
    Get full text
    Article
  16. 16
    CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL

    CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL by Hai-ping Dai, Dan-qing Kong, Hong-jie Shen, Wei Cui, Qian Wang, Zheng Li, Jia Yin, Li-qing Kang, Lei Yu, De-pei Wu, Xiao-wen Tang

    Published 2023-02-01
    Get full text
    Article
  17. 17
    Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report

    Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transpla... by Meng-Yun Li, Zhi-Hong Lin, Ming-Ming Hu, Li-Qing Kang, Xiao-xia Wu, Qi-wei Chen, Xin Kong, Jian Zhang, Hui-Ying Qiu, De-Pei Wu

    Published 2020-08-01
    Get full text
    Article
  18. 18
    Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma

    Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma by Hai-ping Dai, Wei Cui, Qing-ya Cui, Wen-juan Zhu, Hui-min Meng, Min-qing Zhu, Xia-ming Zhu, Lin Yang, De-pei Wu, Xiao-wen Tang

    Published 2022-02-01
    Get full text
    Article
  19. 19
    Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia

    Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia by Xin-Yue Zhang, Xin-Yue Zhang, Hai-Ping Dai, Hai-Ping Dai, Zheng Li, Zheng Li, Jia Yin, Jia Yin, Xing-Ping Lang, Chun-Xiao Yang, Sheng Xiao, Ming-Qing Zhu, Ming-Qing Zhu, Dan-Dan Liu, Dan-Dan Liu, Hong Liu, Hong Liu, Hong-Jie Shen, Hong-Jie Shen, De-Pei Wu, De-Pei Wu, Xiao-Wen Tang, Xiao-Wen Tang

    Published 2021-01-01
    Get full text
    Article
  20. 20
    Combination of Venetoclax and Midostaurin Efficiently Suppressed Relapsed t(8;21)Acute Myeloid Leukemia With Mutant KIT After Failure of Venetoclax Plus Azacitidine Treatment

    Combination of Venetoclax and Midostaurin Efficiently Suppressed Relapsed t(8;21)Acute Myeloid Leukemia With Mutant KIT After Failure of Venetoclax Plus Azacitidine Treatment by Zheng Li, Zheng Li, Jun Wang, Jun Wang, Shuai-Shuai Ge, Shuai-Shuai Ge, Qiao-Cheng Qiu, Qiao-Cheng Qiu, Jia-Hui Du, Shuang-Shuang Shan, Xiang-Dong Shen, Xiang-Dong Shen, Chao-Ling Wan, Chao-Ling Wan, Bin-Ru Wang, Bin-Ru Wang, De-Pei Wu, De-Pei Wu, Hui-Ying Qiu, Hui-Ying Qiu, Sheng-Li Xue, Sheng-Li Xue

    Published 2022-02-01
    Get full text
    Article

Search Tools: